Fagni, F., Schmidt, K., Bohr, D., Valor-Méndez, L., Hartmann, F., Tascilar, K., . . . Harrer, T. (2022). Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination. Friedrich-Alexander-Universität Erlangen-Nürnberg.
Chicago-Zitierstil (17. Ausg.)Fagni, Filippo, et al. Effects of Casirivimab/imdevimab on Systemic and Mucosal Immunity Against SARS-CoV-2 in B-cell Depleted Patients with Autoimmune Rheumatic Diseases Refractory to Vaccination. Erlangen ; Nürnberg: Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.
MLA-Zitierstil (9. Ausg.)Fagni, Filippo, et al. Effects of Casirivimab/imdevimab on Systemic and Mucosal Immunity Against SARS-CoV-2 in B-cell Depleted Patients with Autoimmune Rheumatic Diseases Refractory to Vaccination. Friedrich-Alexander-Universität Erlangen-Nürnberg, 2022.